These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 14748750)

  • 21. Optimal management of peptic ulcer disease in the elderly.
    Pilotto A; Franceschi M; Maggi S; Addante F; Sancarlo D
    Drugs Aging; 2010 Jul; 27(7):545-58. PubMed ID: 20583849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
    Huang JQ; Sridhar S; Hunt RH
    Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
    Soll AH
    JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
    Lai KC; Lam SK; Chu KM; Hui WM; Kwok KF; Wong BC; Hu HC; Wong WM; Chan OO; Chan CK
    Aliment Pharmacol Ther; 2003 Oct; 18(8):829-36. PubMed ID: 14535877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The significance of H. pylori eradication in NSAIDs ulcer].
    Kato M; Ono S; Mabe K; Shimizu Y; Asaka M
    Nihon Rinsho; 2011 Jun; 69(6):1049-56. PubMed ID: 21688626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Consequences of Helicobacter pylori infection on the incidence and treatment of gastro-duodenal ulcers in patients taking non-steroidal anti-inflammatory agents].
    Lamarque D
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1122-4. PubMed ID: 10051998
    [No Abstract]   [Full Text] [Related]  

  • 27. [Guidelines of prevention and treatment for NSAID-related peptic ulcers].
    Lee JH; Lee YC; Jeon SW; Kim JW; Lee SW; ;
    Korean J Gastroenterol; 2009 Nov; 54(5):309-17. PubMed ID: 19934612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
    Chan FK; To KF; Wu JC; Yung MY; Leung WK; Kwok T; Hui Y; Chan HL; Chan CS; Hui E; Woo J; Sung JJ
    Lancet; 2002 Jan; 359(9300):9-13. PubMed ID: 11809180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential location of idiopathic peptic ulcers.
    Iijima K; Kanno T; Abe Y; Yagi M; Asonuma S; Ohyauchi M; Ito H; Koike T; Shimosegawa T
    Scand J Gastroenterol; 2016 Jul; 51(7):782-7. PubMed ID: 26854021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peptic ulcer, Helicobacter pylori].
    Bauerfeind P; Wirth HP
    Ther Umsch; 1997 Nov; 54(11):624-8. PubMed ID: 9454363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Weilert F; Smith AC; Stokes PL
    N Engl J Med; 1998 Jul; 339(5):349; author reply 350-1. PubMed ID: 9696649
    [No Abstract]   [Full Text] [Related]  

  • 33. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
    Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K
    Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
    Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
    Shimada T; Yamagata M; Hiraishi H
    Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
    Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori-negative peptic ulcers: frequency and implications for management.
    Freston JW
    J Gastroenterol; 2000; 35 Suppl 12():29-32. PubMed ID: 10779214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 39. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.